In the clinic for March 2, 2023 March 2, 2023 Clinical updates, including trial initiations, enrollment status and data readouts and publications: 23andme, AB, Ambrx, Atom, Cidara, CSL, Deciphera, Emalex, Imcyse, Iveric, Kancera, Karolinska, Lumos, Merck & Co., Moleculin, PDS, Tachyon.Read More
In the clinic for March 1, 2023 March 1, 2023 Clinical updates, including trial initiations, enrollment status and data readouts and publications: Konica Minolta Healthcare, Otsuka Medical, Recor Medical.Read More
In the clinic for March 1, 2023 March 1, 2023 Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aim, Aldeyra, Aptinyx, Arrowhead, Aslan, Cybin, Eloxx, Innovent, Junshi, JW, Merck & Co., Nascent, Qsam.Read More
In the clinic for Feb. 21-27, 2023 Feb. 28, 2023 Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Alteogen, Amniotics, Ascletis, Aslan, Astellas, Atea, Bridge, Effector, Horizon, Innocare, Junshi, Keymed, Kinarus, Merck, Neurophth, Oscotec, Shionogi, Shionogi, Takeda, Telix, Westvac.Read More
In the clinic for Feb. 28, 2023 Feb. 28, 2023 Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbott, Premia Spine, Pulnovo Medical.Read More
In the clinic for Feb. 28, 2023 Feb. 28, 2023 Clinical updates, including trial initiations, enrollment status and data readouts and publications: Blueprint, Celldex, Chiesi, Clene, Elpiscience, Evelo, Hutchmed, Imunon, Levation, Maze, Mitsubishi Tanabe, Nexcella, Sanofi.Read More
In the clinic for Feb. 27, 2023 Feb. 27, 2023 Clinical updates, including trial initiations, enrollment status and data readouts and publications: Conformal Medical, Medtronic.Read More
In the clinic for Feb. 27, 2023 Feb. 27, 2023 Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aslan, Astria, Atea, Biocryst, Codexis, Fulcrum, Innocare, Keymed, Merck, Nektar, Nestlé, Orchard, Oscotec, Prilenia, Regenxbio, Tvardi, Werewolf.Read More
In the clinic for Feb. 24, 2023 Feb. 24, 2023 Clinical updates, including trial initiations, enrollment status and data readouts and publications: Feops, Sportgait.Read More
In the clinic for Feb. 24, 2023 Feb. 24, 2023 Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D Molecular, Accutar, Amicus, Astellas, Cantargia, Denali, Forge, Horizon, Janssen, Pharmaessentia, Regenxbio, Sangamo, Skye, Theratechnologies, Viiv.Read More